ImageneBio Inc
45 hedge funds and large institutions have $41.9M invested in ImageneBio Inc in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 10 closing their positions.
50% more capital inflows, than outflows
Capital inflows: $4.36M | Capital outflows: $2.92M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.59% less ownership
Funds ownership: 78.77% → 78.18% (-0.59%)
13% less funds holding
Funds holding: 52 → 45 (-7)
65% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 20
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deep Track Capital
Greenwich,
Connecticut
|
+$3.62M |
| 2 |
Aldebaran Capital
Carmel,
Indiana
|
+$356K |
| 3 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$180K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
+$63.1K |
| 5 |
Squarepoint
New York
|
+$48.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Gilead Sciences
Foster City,
California
|
-$1.22M |
| 2 |
Peapod Lane Capital
Bedford Hills,
New York
|
-$304K |
| 3 |
JP Morgan Chase
New York
|
-$223K |
| 4 |
Millennium Management
New York
|
-$187K |
| 5 |
Barclays
London,
United Kingdom
|
-$186K |
IMA Hedge Fund Activity: Q1 2025 in Review
45 of the 7,489 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2025, worth a combined $41.9M — down 19% from $52M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of IMA and 3 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 7 added.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $3.62M. The largest seller was Gilead Sciences, cutting an estimated $1.22M.
- 45 institutional investors held ImageneBio Inc (IMA) as of Q1 2025, down from 52 in Q4 2024.
- Funds reported $41.9M of ImageneBio Inc stock for Q1 2025, down 19% quarter-over-quarter.
- 3 funds opened new ImageneBio Inc positions in Q1 2025 and 10 closed out, a net change of -7 holders.
- The largest ImageneBio Inc buyer in Q1 2025 was Deep Track Capital, an estimated $3.62M added.
- The largest ImageneBio Inc seller in Q1 2025 was Gilead Sciences, an estimated $1.22M sold.
Based on aggregated 13F filings for Q1 2025.